Načítá se...
Continuation of metformin use after a diagnosis of cirrhosis significantly improved survival of patients with diabetes
BACKGROUND: The risks and benefits of metformin use in cirrhotic patients with diabetes are debated. Although data on a protective effect of metformin against liver cancer development have been reported, metformin is frequently discontinued once cirrhosis is diagnosed due to concerns about an increa...
Uloženo v:
| Vydáno v: | Hepatology |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218882/ https://ncbi.nlm.nih.gov/pubmed/24798175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27199 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|